Clene Inc
(NAS:CLNN)
$
4.1
-0.08 (-1.91%)
Market Cap: 32.72 Mil
Enterprise Value: 41.59 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 42/100 Clene Inc. at ROTH Conference Transcript
Mar 13, 2023 / 07:30PM GMT
Release Date Price:
$27.2
(+7.94%)
Jonathan Ashcoff
ROTH MKM - Analyst
Again, I'm Jonathan Ashcoff, Senior Biotechnology Analyst at ROTH MKM. And now with us we have Rob Etherington, the CEO of Clene Inc.
Rob Etherington
Clene Inc. - President & CEO
Thank you, Jonathan. Pleasure to be here.
Jonathan Ashcoff
ROTH MKM - Analyst
Welcome, Rob.
Questions & Answers
Jonathan Ashcoff
ROTH MKM - Analyst
So let's discuss your main product, CNM-Au8. A lot of people are probably unfamiliar with it. How does it work? What makes it unique? Is this alchemy or is this really gold?
Rob Etherington
Clene Inc. - President & CEO
So it's a -- CNM-Au8 is a gold nanocrystal suspension. The only such drug of its type that we are aware where the therapy is the asset itself. In other words, there's gold nanocrystals that one could use for drug delivery, there's gold nanocrystals that one could use to paint an asset, another asset on, there's gold nanocrystals
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot